Trastuzumab Deruxtecan Treatment for Metastatic HER2+ Breast Cancer with Brain Metastases

Experts have a conversation of the use of trastuzumab deruxtecan therapy for patients with progressive brain metastases while weighing common toxicities and clinical trial data.

Related Videos
Experts on GVHD with a patient
Experts on GVHD with a patient
Experts on RCC
Experts on RCC
Experts on breast cancer
Experts on breast cancer
Experts on RCC
Experts on RCC
Related Content